The company aims to deliver an innovative, low-cost colonoscopy solution called EndoNav's RigiFlexTM disposable Over-the-Scope (OTS) device that eliminates the need for painful sedation and increases procedure throughput. The solution addresses problems with traditional colonoscopy scopes that cause looping and damage to the colon. It is estimated to decrease procedure time, increase revenue, reduce complications, and have a shorter learning curve for physicians. Financial projections estimate the company will have positive net income within 3 years and an overall internal rate of return of 99%.